Regencell Bioscience Holdings Limited (RGC) vs Veracyte, Inc. (VCYT)

A side-by-side comparison of Regencell Bioscience Holdings Limited and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — RGC vs VCYT

growth of $100 · dividends reinvested · last 5y
RGC +2520.2% (+92.2%/yr)VCYT +25.0% (+4.6%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
101001k10k100kStart $10020222023202420252026$2,620$125
RGC VCYT

RGC vs VCYT: by the numbers

  • •RGC is the larger company ($3.64B vs $3.56B market cap).
  • •VCYT is profitable (20.37% net margin) while RGC runs a net loss (0.00%).

Metrics side by side

Valuation

MetricRGCVCYT
P/E ratioN/A31.89
Forward P/EN/A23.33
P/S ratioN/A6.34
P/B ratio2986.542.57
EV / EBITDAN/A28.34
FCF yieldN/A4.64%

Profitability

MetricRGCVCYT
Gross margin0.00%72.09%
Operating margin0.00%17.03%
Net margin0.00%20.37%
ROE-73.75%8.25%
ROIC-69.75%6.72%

Growth (annualized)

MetricRGCVCYT
Revenue CAGR (5Y)N/A28.98%
Total return CAGR (5Y)67.94%1.45%

Frequently asked

Is RGC or VCYT more profitable?
VCYT runs the higher net margin — RGC at 0.00% versus VCYT at 20.37%.
How have RGC and VCYT total returns compared?
Over the past 5 years, RGC delivered 67.94% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.